Chengshi Xu Selected Research

Chengshi Xu Research Topics

2	Glioma (Gliomas) 02/2024 - 01/2011
2	Neoplasms (Cancer) 02/2024 - 01/2013
2	Wounds and Injuries (Trauma) 01/2023 - 01/2018
2	Pain (Aches) 05/2020 - 01/2016
2	Hypoxia (Hypoxemia) 01/2013 - 01/2011
1	Unconsciousness (Loss of Consciousness) 01/2024
1	COVID-19 01/2023
1	Ischemic Stroke 01/2022
1	Brain Ischemia (Cerebral Ischemia) 01/2022
1	Acute Subdural Hematoma 01/2018
1	Chronic Subdural Hematoma 01/2018
1	Hematoma 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 02/2017
1	Nervous System Diseases (Neurological Disorders) 01/2015
1	Carcinogenesis 01/2013
1	Glioblastoma (Glioblastoma Multiforme) 01/2013
1	Scoliosis 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 01/2012

2	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 01/2011
1	ProteomeIBA 02/2024
1	Proteins (Proteins, Gene)FDA Link 02/2024
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2024
1	Glutamic Acid (Glutamate)FDA Link 01/2024
1	Anesthetics (Anesthetic Agents)IBA 01/2024
1	CalciumIBA 01/2024
1	gamma-Aminobutyric Acid (GABA)IBA 01/2024
1	SolutionsIBA 01/2023
1	cilgavimabIBA 01/2023
1	tixagevimabIBA 01/2023
1	TrehaloseIBA 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 05/2020
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2015
1	Adenosine Triphosphate (ATP)IBA 01/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2013
1	Isoflurane FDA LinkGeneric 01/2012
1	BatroxobinIBA 01/2012
1	Tranexamic Acid (AMCA)FDA Link 01/2012
1	Saline SolutionIBA 01/2012
1	delta proteinIBA 01/2011
1	LigandsIBA 01/2011

1	Therapeutics 01/2022
1	Transplantation 01/2022
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 05/2020
1	General Anesthesia 05/2020
1	Craniotomy 01/2018
1	Endoscopes 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 02/2017
1	Anesthesia 01/2016
1	Blood Transfusion (Blood Transfusions) 01/2012